Skip to main content
Nature Communications logoLink to Nature Communications
. 2022 Oct 3;13:5833. doi: 10.1038/s41467-022-33668-0

Author Correction: [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease

Tharick A Pascoal 1,2,3,4, Mira Chamoun 1, Elad Lax 5,6, Hsiao-Ying Wey 6, Monica Shin 1, Kok Pin Ng 1, Min Su Kang 1,4, Sulantha Mathotaarachchi 1, Andrea L Benedet 1, Joseph Therriault 1, Firoza Z Lussier 1, Frederick A Schroeder 7, Jonathan M DuBois 7, Baileigh G Hightower 7, Tonya M Gilbert 7, Nicole R Zürcher 7, Changning Wang 7, Robert Hopewell 4, Mallar Chakravarty 8, Melissa Savard 1, Emilie Thomas 1, Sara Mohaddes 1, Sarah Farzin 8, Alyssa Salaciak 8, Stephanie Tullo 8, A Claudio Cuello 6, Jean-Paul Soucy 4, Gassan Massarweh 4, Heungsun Hwang 9, Eliane Kobayashi 4, Bradley T Hyman 10, Bradford C Dickerson 7,9, Marie-Christine Guiot 4, Moshe Szyf 6, Serge Gauthier 1, Jacob M Hooker 7, Pedro Rosa-Neto 1,4,
PMCID: PMC9529935  PMID: 36192402

Correction to: Nature Communications 10.1038/s41467-022-30653-5, published online 19 July 2022

In this article the funding from ‘Alzheimer’s Drug Discovery Foundation (ADDF)’ was omitted. The original article has been corrected.


Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES